OncClubAll Oncology News
InsightsMedNews WeekOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid Readouts
Conference CoverageConference Listing
Giants of Cancer CareCME/CEScientific InterchangesState of the Science Summit / IPCNational Fellows ForumWebinars
PartnersPublications
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker ConsortiumSubscribe
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Pediatric Oncology
Precision Medicine in Oncology®
Sarcomas
Supportive Care
Spotlight -
  • The OncLive Insider app is live!
  • CME Opportunities
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Pediatric Oncology
Precision Medicine in Oncology®
Sarcomas
Supportive Care
    • Partners
    • Publications
    • Biomarker Consortium
    • Subscribe

Your AI-Trained Oncology Knowledge Connection!

scout
Advertisement

Breast Cancer: A Continuum of Care

home / peer-exchange / breast10-care-continuum
Breast Cancer: Genomic Testing for Adjuvant Therapy

EP. 1: Breast Cancer: Genomic Testing for Adjuvant Therapy

February 22nd 2017
MINDACT Trial Design and Results in Breast Cancer

EP. 2: MINDACT Trial Design and Results in Breast Cancer

February 22nd 2017
Breast Cancer: Genomic Testing

EP. 3: Breast Cancer: Genomic Testing

February 22nd 2017
Comparison of Prognostic Tests in Breast Cancer

EP. 4: Comparison of Prognostic Tests in Breast Cancer

February 22nd 2017
Breast Cancer: Extended Adjuvant Endocrine Therapy

EP. 5: Breast Cancer: Extended Adjuvant Endocrine Therapy

February 22nd 2017
FALCON Trial Data in HR+ Metastatic Breast Cancer

EP. 6: FALCON Trial Data in HR+ Metastatic Breast Cancer

February 22nd 2017
Ribociclib for HR+ Advanced Breast Cancer

EP. 7: Ribociclib for HR+ Advanced Breast Cancer

February 22nd 2017
Emerging Role of Abemaciclib for HR+ Advanced Breast Cancer

EP. 8: Emerging Role of Abemaciclib for HR+ Advanced Breast Cancer

February 22nd 2017
Everolimus for HR+ Metastatic Breast Cancer

EP. 9: Everolimus for HR+ Metastatic Breast Cancer

February 22nd 2017
PI3K Inhibitors in HR+ Metastatic Breast Cancer

EP. 10: PI3K Inhibitors in HR+ Metastatic Breast Cancer

February 22nd 2017
HER2-Targeted Therapy in Early Stage HER2+ Breast Cancer

EP. 11: HER2-Targeted Therapy in Early Stage HER2+ Breast Cancer

February 22nd 2017
Extended Adjuvant Therapy for HER2+ Early Breast Cancer

EP. 12: Extended Adjuvant Therapy for HER2+ Early Breast Cancer

February 22nd 2017
Treating HER2+ Metastatic Breast Cancer

EP. 13: Treating HER2+ Metastatic Breast Cancer

February 22nd 2017
BRCA1/2 Status and Homologous Repair Deficiency in TNBC

EP. 14: BRCA1/2 Status and Homologous Repair Deficiency in TNBC

February 22nd 2017
Immunotherapy for TNBC

EP. 15: Immunotherapy for TNBC

February 22nd 2017
Antibody-Drug Conjugates for TNBC

EP. 16: Antibody-Drug Conjugates for TNBC

February 22nd 2017

Latest Conference Coverage

First-Line Rucaparib Maintenance Reduces Progression Risk Across Prognostic Subgroups in HRD– High-Grade Ovarian Cancer

Raludotatug Deruxtecan Shows Activity in Platinum-Sensitive Ovarian Cancer

Relacorilant/Nab-Paclitaxel Is Associated With Survival Improvement in Platinum-Resistant Ovarian Cancer After Short Platinum-Free Interval

PD-L1 CPS Does Not Enrich the Efficacy of Atezolizumab/Bevacizumab and Chemo in Advanced Cervical Cancer

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
MJH Life Sciences brands
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

Download on Apple
© 2025 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact